CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 8,334 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 8,334 shares (grant or award)
- 4 Grant or award Chief Research Officer acquired 833 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 833 shares (grant or award)
- 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
- 4 Exercise or conversion Director acquired 4,202 shares (option exercise)
- 4 Grant or award Chief Financial Officer acquired 506 shares (grant or award)
- 4 Planned sale General Counsel and Secretary sold 272 shares at $10.32 ($2,807)
- 4 Open-market sale Chief Research Officer sold 154 shares at $10.32 ($1,589)
- 4 Open-market sale Chief Medical Officer sold 290 shares at $10.32 ($2,993)
- 4 Open-market sale President and CEO sold 1,526 shares at $10.32 ($15,748)
- 4 Open-market sale Chief Medical Officer sold 238 shares at $10.03 ($2,386)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 14 · 269 filings